Efficacy of sagenit in menopausal syndrome
- Autores: Smetnik VP1, Smetnik VP1
-
Afiliações:
- Edição: Nº 4 (2010)
- Páginas: 94-96
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246428
- ID: 246428
Citar
Texto integral
Resumo
A double-blind placebo-controlled multicenter study of Sagenit was conducted in menopausal patients. Thirty-four women received the drug as a tablet (0.1 g) daily. Therapy was performed for 9 months. Placebo was also given to 36 patients during the same period. Sagenit turned out to be highly effective in abolishing neurovegetative and psychoemotional symptoms. Even when used long continuously for 9 months, the agent caused no adverse reactions, such as endometrial proliferation, and had no effect on the breast. Thus, the use of sagenit may be an alternative to hormonal replacement therapy.
Palavras-chave
Bibliografia
Arquivos suplementares
